Analyze Diet
Frontiers in veterinary science2025; 12; 1515833; doi: 10.3389/fvets.2025.1515833

Pharmacokinetics of a single oral administration of two cannabidiol formulations in fed and fasted horses.

Abstract: Pain management in horses plays a pivotal role in the therapeutic approach to several diseases. Horses have cannabinoid receptors at the level of dorsal root ganglia, blood vessels, and synoviocytes that can be up or down- regulated by inflammatory conditions, justifying the possible efficacy of exogenous cannabinoids (i.e., phytocannabinoids) in managing several painful pathologies in this animal species. However, the current use of supplements containing cannabidiol (CBD) in equines is based on anecdotal evidence, without the support of sufficient pharmacokinetic studies. In humans, the concentration peak of CBD and the area under the concentration-time curve (AUC) are both strongly influenced by food administration. Also, in equids, the oral bioavailability of some drugs can be influenced by the meal but no information is available about CBD. This study investigated the pharmacokinetics of CBD following single oral administration of two different formulations of pure CBD (oil and paste), dosed at 1 mg/kg, at two different times about food administration. CBD oil and CBD paste were administered orally at 1 mg/kg to eight healthy horses according to a cross over design, and blood samples were taken at pre-fixed time-points for the pharmacokinetic analyses. The obtained pharmacokinetic data did not allow for statistically significant differences between formulations (paste or oil) and feeding time (fed and fasted status). However, following treatment with the paste, the Cmax was achieved in a shorter time range compared to the oily formulation, indicating that it could be a better formulation to consider in future equine studies.
Publication Date: 2025-02-19 PubMed ID: 40046423PubMed Central: PMC11880937DOI: 10.3389/fvets.2025.1515833Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article explores the pharmacokinetics of two formulations of cannabidiol (CBD) – oil and paste – on horses in fed and fasted states. It seeks to determine the most effective administration method for managing equine pain.

Research Basis

  • The study was motivated by the lack of pharmacokinetic studies supporting the use of CBD supplements in horses, despite anecdotal evidence suggesting efficacy. Horses have cannabinoid receptors which can be influenced by inflammation, hence the potential of cannabinoids in pain management.
  • In humans, factors such as food ingestion greatly influence the behavior of CBD in the body. The researchers sought to determine if meal timing has a similar effect in horses, and how the different CBD formulations affect this.

Methodology

  • The researchers administered 1 mg/kg of CBD oil and CBD paste to eight healthy horses. The dose was given at different times relative to food consumption.
  • The researchers then took blood samples at various points in time following CBD administration for pharmacokinetic analysis.

Results and Findings

  • The study didn’t find statistically significant differences between the effects of the oil and paste formulations, or between administering the CBD when the horses had eaten compared to when they were fasted.
  • However, the study did note that the CBD paste achieved a maximum concentration (Cmax) in the blood in less time than the CBD oil did. This suggests that future studies on CBD administration in horses may want to consider CBD paste as the potentially superior formulation.
  • Implications of the Study

    • While the research didn’t conclusively rule in favor of one formulation or feeding time over another, it does suggest that CBD paste may be the more efficient formulation for equine studies.
    • The study provides vital information for future research into the use of CBD for pain management in horses and other animals with similar cannabinoid receptor configurations.
    • Rather than confirming the benefits of one particular method, the study raises additional questions and avenues for investigation. This contributes to the overall understanding of CBD use in veterinary practices and can act as a reference point for further inquiries into this area.

    Cite This Article

    APA
    (2025). Pharmacokinetics of a single oral administration of two cannabidiol formulations in fed and fasted horses. Front Vet Sci, 12, 1515833. https://doi.org/10.3389/fvets.2025.1515833

    Publication

    ISSN: 2297-1769
    NlmUniqueID: 101666658
    Country: Switzerland
    Language: English
    Volume: 12
    Pages: 1515833
    PII: 1515833

    Researcher Affiliations

    Conflict of Interest Statement

    MM was employed by Farmacia San Carlo. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

    References

    This article includes 40 references
    1. Di Salvo A, Conti MB, Della Rocca G. Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge.. Front Vet Sci (2023) 10:1–15.
      doi: 10.3389/fvets.2023.1204526pmc: PMC10347378pubmed: 37456953google scholar: lookup
    2. Galiazzo G, De Silva M, Giancola F, Rinnovati R, Peli A, Chiocchetti R. Cellular distribution of cannabinoid-related receptors TRPV1, PPAR-gamma, GPR55 and GPR3 in the equine cervical dorsal root ganglia.. Equine Vet J (2022) 54:788–98.
      doi: 10.1111/evj.13499pmc: PMC9293124pubmed: 34418142google scholar: lookup
    3. Chiocchetti R, Rinnovati R, Tagliavia C, Stanzani A, Galiazzo G, Giancola F. Localisation of cannabinoid and cannabinoid-related receptors in the equine dorsal root ganglia.. Equine Vet J (2021) 53:549–57.
      doi: 10.1111/evj.13305pubmed: 32524649google scholar: lookup
    4. Miagkoff L, Girard CA, St-Jean G, Richard H, Beauchamp G, Laverty S. Cannabinoid receptors are expressed in equine synovium and upregulated with synovitis.. Equine Vet J (2023) 55:681–95.
      doi: 10.1111/evj.13860pubmed: 35836386google scholar: lookup
    5. Zamith Cunha R, Zannoni A, Salamanca G, De Silva M, Rinnovati R, Gramenzi A. Expression of cannabinoid (CB1 and CB2) and cannabinoid-related receptors (TRPV1, GPR55, and PPARα) in the synovial membrane of the horse metacarpophalangeal joint.. Front Vet Sci (2023) 10:1045030.
      doi: 10.3389/fvets.2023.1045030pmc: PMC10020506pubmed: 36937015google scholar: lookup
    6. St Blanc MP, Chapman AM, Keowen ML, Garza F, Liu C-C, Gray L. Effects of a supplement containing Cannabidiol (CBD) on sedation and Ataxia scores and health.. J Equine Vet (2022) 117:104085.
      doi: 10.1016/j.jevs.2022.104085pubmed: 35882292google scholar: lookup
    7. Thomson ACS, McCarrel TM, Zakharov A, Gomez B, Lyubimov A, Schwark WS. Pharmacokinetics and tolerability of single-dose enteral cannabidiol and cannabidiolic acid rich hemp in horses (Equus caballus).. Front Vet Sci (2024) 11:1356463.
      doi: 10.3389/fvets.2024.1356463pmc: PMC11047043pubmed: 38681854google scholar: lookup
    8. Turner SE, Knych HK, Adams AA. Pharmacokinetics of cannabidiol in a randomized crossover trial in senior horses.. Am J Vet Res (2022) 83:1–7.
      doi: 10.2460/ajvr.22.02.0028pubmed: 35895770google scholar: lookup
    9. Ryan D, McKemie DS, Kass PH, Puschner B, Knych HK. Pharmacokinetics and effects on arachidonic acid metabolism of low doses of cannabidiol following oral administration to horses.. Drug Test Anal (2021) 13:1305–17.
      doi: 10.1002/dta.3028pubmed: 33723919google scholar: lookup
    10. Sánchez De Medina A, Serrano-Rodríguez JM, Díez De Castro E, García-Valverde MT, Saitua A, Becero M. Pharmacokinetics and oral bioavailability of cannabidiol in horses after intravenous and oral administration with oil and micellar formulations.. Equine Vet J (2023) 55:1094–103.
      doi: 10.1111/evj.13923pubmed: 36624043google scholar: lookup
    11. Yocom AF, O’Fallon ES, Gustafson DL, Contino EK. Pharmacokinetics, safety, and synovial fluid concentrations of single- and multiple-dose Oral administration of 1 and 3 mg/kg Cannabidiol in horses.. J Equine Vet (2022) 113:103933.
      doi: 10.1016/j.jevs.2022.103933pubmed: 35307550google scholar: lookup
    12. Williams MR, Holbrook TC, Maxwell L, Croft CH, Ientile MM, Cliburn K. Pharmacokinetic evaluation of a Cannabidiol supplement in horses.. J Equine Vet (2022) 110:103842.
      doi: 10.1016/j.jevs.2021.103842pubmed: 34923070google scholar: lookup
    13. Eichler F, Poźniak B, Machnik M, Schenk I, Wingender A, Baudisch N. Pharmacokinetic modelling of orally administered cannabidiol and implications for medication control in horses.. Front Vet Sci (2023) 10:1234551.
      doi: 10.3389/fvets.2023.1234551pmc: PMC10445762pubmed: 37621871google scholar: lookup
    14. Taylor L, Gidal B, Blakey G, Tayo B, Morrison G. A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified Cannabidiol in healthy subjects.. CNS Drugs (2018) 32:1053–67.
      doi: 10.1007/s40263-018-0578-5pmc: PMC6223703pubmed: 30374683google scholar: lookup
    15. Stott CG, White L, Wright S, Wilbraham D, Guy GW. A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray.. Eur J Clin Pharmacol (2013) 69:825–34.
      doi: 10.1007/s00228-012-1393-4pubmed: 23052407google scholar: lookup
    16. Song Y, Day CM, Afinjuomo F, Tan J-QE, Page SW, Garg S. Advanced strategies of drug delivery via Oral, topical, and parenteral administration routes: where do equine medications stand?. Pharmaceutics (2023) 15:186.
    17. Pandopulos AJ, Bade R, O’Brien JW, Tscharke BJ, Mueller JF, Thomas K. Towards an efficient method for the extraction and analysis of cannabinoids in wastewater.. Talanta (2020) 217:121034.
      doi: 10.1016/j.talanta.2020.121034pubmed: 32498913google scholar: lookup
    18. Cliburn KD, Huestis MA, Wagner JR, Kemp PM. Identification and quantification of cannabinoids in postmortem fluids and tissues by liquid chromatography-tandem mass spectrometry.. J Chromatogr A (2021) 1652:462345.
      doi: 10.1016/j.chroma.2021.462345pubmed: 34198104google scholar: lookup
    19. Zhang Y, Huo M, Zhou J, Xie S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft excel.. Comput Methods Prog Biomed (2010) 99:306–14.
      doi: 10.1016/j.cmpb.2010.01.007pubmed: 20176408google scholar: lookup
    20. Della Rocca G, Paoletti F, Conti MB, Galarini R. Pharmacokinetics of cannabidiol following single oral and oral transmucosal administration in dogs.. Front Vet Sci (2023) 9:1104152.
      doi: 10.3389/fvets.2022.1104152pmc: PMC9859632pubmed: 36686155google scholar: lookup
    21. Ellis KL, Contino EK. Treatment using cannabidiol in a horse with mechanical allodynia.. Equine Vet Educ (2021) 33:e79–e82.
      doi: 10.1111/eve.13168google scholar: lookup
    22. Cunha RZ, Felisardo LL, Salamanca G, Marchioni GG, Neto OI, Chiocchetti R. The use of cannabidiol as a novel treatment for oral stereotypic behaviour (crib-biting) in a horse.. Vet Anim Sci (2023) 19:100289.
      doi: 10.1016/j.vas.2023.100289pmc: PMC9941357pubmed: 36824298google scholar: lookup
    23. Brioschi FA, Di Cesare F, Gioeni D, Rabbogliatti V, Ferrari F, D’Urso ES. Oral Transmucosal Cannabidiol oil formulation as part of a multimodal analgesic regimen: effects on pain relief and quality of life improvement in dogs affected by spontaneous osteoarthritis.. Animals (2020) 10:1505.
      doi: 10.3390/ani10091505pmc: PMC7552307pubmed: 32858828google scholar: lookup
    24. Lundström T, Lingström P, Wattle O, Carlén A, Birkhed D. Equine saliva components during mastication, and in vivo pH changes in the oral biofilm of sound and carious tooth surfaces after sucrose exposure.. Acta Vet Scand (2020) 62:21.
      doi: 10.1186/s13028-020-00518-2pmc: PMC7245034pubmed: 32446309google scholar: lookup
    25. Di Salvo A, Chiaradia E, Sforna M. Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review.. Vet Res Commun (2024) 48:2915–41.
      doi: 10.1007/s11259-024-10509-7pmc: PMC11442603pubmed: 39162768google scholar: lookup
    26. DiMaio Knych HK, Stanley SD. Pharmacokinetics and pharmacodynamics of detomidine following sublingual administration to horses.. Am J Vet Res (2011) 72:1378–85.
      doi: 10.2460/ajvr.72.10.1378pubmed: 21962281google scholar: lookup
    27. Kaukinen H, Aspegrén J, Hyyppä S, Tamm L, Salonen JS. Bioavailability of detomidine administered sublingually to horses as an oromucosal gel.. J Vet Pharmacol Ther (2011) 34:76–81.
    28. Hedges AR, Pypendop BH, Shilo Y, Stanley SD, Ilkiw JE. Impact of the blood sampling site on time–concentration drug profiles following intravenous or buccal drug administration.. J Vet Pharmacol Ther (2014) 37:145–50.
      doi: 10.1111/jvp.12075pubmed: 24745064google scholar: lookup
    29. Martinez MN, Papich MG, Fahmy R. Impact of gastrointestinal differences in veterinary species on the oral drug solubility, in vivo dissolution, and formulation of veterinary therapeutics.. ADMET DMPK (2022) 10:1–25.
      doi: 10.5599/admet.1140pmc: PMC8963575pubmed: 35360673google scholar: lookup
    30. Davies NM, Takemoto JK, Brocks DR, Yáñez JA. Multiple peaking phenomena in pharmacokinetic disposition.. Clin Pharmacokinet (2010) 49:351–77.
    31. Limsuwan S, Phonsatta N, Panya A, Asasutjarit R, Tansakul N. Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs.. Front Vet Sci (2024) 11:1389810.
      doi: 10.3389/fvets.2024.1389810pmc: PMC11080651pubmed: 38725584google scholar: lookup
    32. Chicoine A, Illing K, Vuong S, Pinto KR, Alcorn J, Cosford K. Pharmacokinetic and safety evaluation of various Oral doses of a novel 1:20 THC:CBD Cannabis herbal extract in dogs.. Front Vet Sci (2020) 7:1–12.
      doi: 10.3389/fvets.2020.583404pmc: PMC7550466pubmed: 33134364google scholar: lookup
    33. Doran CE, McGrath S, Bartner LR, Thomas B, Cribb AE, Gustafson DL. Drug-drug interaction between cannabidiol and phenobarbital in healthy dogs.. Am J Vet Res (2022) 83:86–94.
      doi: 10.2460/ajvr.21.08.0120pubmed: 34727050google scholar: lookup
    34. Jukier T, Cruz-Espindola C, Martin D, Boothe DM. Disposition of a single oral dose of a cannabidiol medication in healthy cats.. Front Vet Sci (2023) 10:1181517.
      doi: 10.3389/fvets.2023.1181517pmc: PMC10251743pubmed: 37303724google scholar: lookup
    35. Rooney TA, Carpenter JW, KuKanich B, Gardhouse SM, Magnin GC, Tully TN. Feeding decreases the oral bioavailability of cannabidiol and cannabidiolic acid in hemp oil in New Zealand White rabbits (Oryctolagus cuniculus).. Am J Vet Res (2022) 83:1–7.
      doi: 10.2460/ajvr.22.01.0006pubmed: 35947680google scholar: lookup
    36. Bermingham E, Davis JL, Whittem T. Study design synopsis: designing and performing pharmacokinetic studies for systemically administered drugs in horses.. Equine Vet J (2020) 52:643–50.
      doi: 10.1111/evj.13312pubmed: 32748990google scholar: lookup
    37. Interlandi C, Tabbì M, Di Pietro S. Improved quality of life and pain relief in mature horses with osteoarthritis after oral transmucosal cannabidiol oil administration as part of an analgesic regimen.. Front Vet Sci (2024) 11:1341396.
      doi: 10.3389/fvets.2024.1341396pmc: PMC10876772pubmed: 38379920google scholar: lookup
    38. Aragona F, Tabbì M, Gugliandolo E, Giannetto C, D'Angelo F, Fazio F. Role of cannabidiolic acid or the combination of cannabigerol/cannabidiol in pain modulation and welfare improvement in horses with chronic osteoarthritis.. Front Vet Sci (2024) 11:1496473.
      doi: 10.3389/fvets.2024.1496473pmc: PMC11668182pubmed: 39720409google scholar: lookup
    39. . Method of reducing stress and anxiety in equines.. United States Patent 2020 Apr; Patent No.: US 10,624,936 B2.
    40. McIver V, Tsang A, Symonds N, Perkins N, Uquillas E, Dart C. Effects of topical treatment of cannabidiol extract in a unique manuka factor 5 manuka honey carrier on second intention wound healing on equine distal limb wounds: a preliminary study.. Aust Vet J (2020) 98:250–5.
      doi: 10.1111/avj.12932pubmed: 32096215google scholar: lookup

    Citations

    This article has been cited 0 times.